Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.62 |
| ▸ | SLC1A1 | P43005 | 5/20 | 0.56 |
| ▸ | SLC1A3 | P43003 | 5/20 | 0.54 |
| ▸ | SLC1A2 | P43004 | 5/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.52 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.52 |
| ▸ | GRIK1 | P39086 | 4/20 | 0.50 |
| ▸ | GRIK2 | Q13002 | 4/20 | 0.50 |
| ▸ | GGT1 | P19440 | 2/20 | 0.50 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.50 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL39093 | 1.00 | SLC7A5 (0.62) | SLC7A5SLC1A1SLC1A3SLC1A2PTGS1 | |
| SCHEMBL4303994 | 1.00 | SLC7A5 (0.62) | SLC7A5SLC1A1SLC1A3SLC1A2PTGS1 | |
| SCHEMBL445471 | 1.00 | SLC7A5 (0.62) | SLC7A5SLC1A1SLC1A3SLC1A2PTGS1 | |
| Glycine SCHEMBL10994359 | 0.89 | SLC7A5 (0.52) | SLC7A5SLC1A1SLC1A3SLC1A2PTGS1 | |
| Aspartic Acid SCHEMBL22557639 | 0.89 | SLC7A5 (0.52) | SLC7A5SLC1A1SLC1A3SLC1A2PTGS1 | |
| Serine SCHEMBL6827952 | 0.89 | SLC1A1 (0.60) | SLC7A5SLC1A1SLC1A3SLC1A2PTGS1 | |
| Alanine SCHEMBL10991017 | 0.89 | SLC7A5 (0.65) | SLC7A5SLC1A1SLC1A3SLC1A2PTGS1 | |
| SCHEMBL600881 | 0.87 | SLC7A5 (0.68) | SLC7A5SLC1A1SLC1A3SLC1A2PTGS1 | |
| SCHEMBL9545322 | 0.87 | SLC7A5 (0.68) | SLC7A5SLC1A1SLC1A3SLC1A2PTGS1 | |
| SCHEMBL29024969 | 0.87 | SLC7A5 (0.68) | SLC7A5SLC1A1SLC1A3SLC1A2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2711 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250268982-A1 | COMPOSITIONS AND METHODS FOR TREATMENT AND/OR PROPHYLAXIS OF PROTEINOPATHIES | REGAIN THERAPEUTICS SWEDEN AB (SE) | 2025-08-28 | — | — | US | claimed |
| US-20250145644-A1 | PROCESSES AND COMPOUNDS FOR PREPARING SPIROLIGOMERS | TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2025-05-08 | — | — | US | claimed |
| US-12290570-B2 | Antibody comprising a glutamine-containing light chain C-terminal extension, conjugates thereof, and methods and uses | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-05-06 | — | — | US | claimed |
| EP-4519299-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TFR1) | BicycleTx Limited (GB) | 2025-03-12 | — | — | EP | claimed |
| WO-2025038979-A1 | COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND/OR TREATMENT OF AMYLOID B PEPTIDE PROTEINOPENIA IN ALZHEIMER'S AND OTHER DISEASES | LVIS-Regain LP (US) | 2025-02-20 | — | — | WO | claimed |
| EP-4475826-A2 | PROCESSES AND COMPOUNDS FOR PREPARING SPIROLIGOMERS | Temple University Of The Commonwealth System Of Higher Education (US) | 2024-12-18 | — | — | EP | claimed |
| CN-119031941-A | Novel antibody-drug conjugates | 阿比蒂斯有限公司 | 2024-11-26 | — | — | CN | claimed |
| CN-119032097-A | Methods and compounds for preparing spiro oligomers | 宾夕法尼亚州高等教育系统天普大学 | 2024-11-26 | — | — | CN | claimed |
| US-20240368225-A1 | SELECTIVE SMALL MOLECULE AGONISTS AND PARTIAL AGONISTS OF TRK RECEPTORS | THE TEXAS A&M UNIVERSITY SYSTEM | 2024-11-07 | — | — | US | claimed |
| CN-118790963-A | Stabilization method of nano amorphous calcium phosphate | 浙江大学 | 2024-10-18 | — | — | CN | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| EP-0748817-A2 | Parathyroid hormone derivatives and their use | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-12-18 | — | — | EP | claimed |
| WO-1995017421-A1 | PEPTIDE ANALOGS OF THE FACTOR IXa PLATELET BINDING SITE | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 1995-06-29 | — | — | WO | claimed |
| EP-0345614-B1 | Amblyommine as an agent for use in antithrombotic therapy | HOECHST AG (DE) | 1994-06-22 | — | — | EP | claimed |
| EP-0226304-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1991-08-28 | — | — | EP | claimed |
| EP-0418617-A1 | Method for preparing human osteocalcin | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1991-03-27 | — | — | EP | claimed |
| US-4761471-A | INDUCE BONE FORMATION IN ANIMALS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1988-08-02 | — | — | US | claimed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | claimed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | claimed |
| CN-86107574-A | Compositions containing penem or carbapenem antibiotics and their use | — | 1987-05-20 | — | — | CN | claimed |